Patient study using a newly developed amiloid imaging PET tracer: [18F]FPYBF-2

Patient study using a newly developed amiloid imaging PET tracer: [18F]FPYBF-2 - Patient study using a newly developed amiloid imaging PET tracer: [18F]FPYBF-2

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012297

Enrollment

Registered

2013-11-14

Start date

2013-10-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia and its related diseases

Interventions

injection of radioisotope

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with dementia and its related diseases

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Evaluation of diagnostic usefulness of [18F]FPYBF-2 in patients who are clinically diagnosed as dementia and its related diseases (comparison between clinical diagnosis and imaging diagnosis).	—

Secondary

Measure	Time frame
Evaluation of prognostic usefulness of [18F]FPYBF-2 in patients with mild cognitive imapairment who developed dementia later.	—

Countries

Japan

Contacts

Public ContactShimomura Shigenori

Shiga Medical Center Research Institute head office

kenkyu@res.med.shiga-pref.jp0775-82-6034

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026